Back to Article List

Denied health claims on lactose digestion, DNA integrity and improved arterial stiffness

European Union

May 13, 2022

Commission Regulation (EU) 2022/719 of 10 May 2022 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health.

Rejected health claims

Application – Relevant provisions of Regulation (EC) No 1924/2006

Nutrient, substance, food or food category

Claim

EFSA opinion reference

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Bifidobacterium animalis subsp. lactis Bi-07 (Bi-07)

Bifidobacterium animalis subsp. lactis Bi-07 contributes to the improvement of lactose digestion in individuals who have difficulty digesting lactose

Q-2020-00024

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Coffee C21, a blend of pure Arabica roast coffees (Coffea arabica L.) without any non-coffee ingredients

Regular consumption of Coffee C21 contributes to the maintenance of DNA integrity in cells of the body

Q-2019-00423

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

MenaQ7®, vitamin K2 as menaquinone-7

MenaQ7®, vitamin K2 as menaquinone-7, improves arterial stiffness

Q-2019-00229

 

For further information (in English), click on the Link

Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox